Epstein Secrets

ed funds to the American Alzheimer's Association, has heralded new findings into the late developing disease. The findings come from researchers at Mount Sinai Hospital in New York City, the Icelandic Heart Association, Sage Bionetworks and Merck Research Laboratories, who have determined that a cluster of genes co

onset of late Alzheimers. The discovery is critical, explains Dr. Bin Zhang, a co-lead author of the study and Associate Professor of Genetics and Genomic Sciences at Mount Sinai. Because we can now "evaluate drugs that impact the TREM2-TYROBP pathway as potential therapies... and design more specific compounds

ed funds to the American Alzheimer's Association, has heralded new findings into the late developing disease. The findings come from researchers at Mount Sinai Hospital in New York City, the Icelandic Heart Association, Sage Bionetworks and Merck Research Laboratories, who have determined that a cluster of genes co

ntly connected to Alzheimer's. The discovery is critical, Dr. Bin Zhang explained, a co-author of the study and Associate Professor of Genetics and Genomic Sciences at Mount Sinai. "We can now evaluate drugs that impact the TFtEM2- TYROBP pathway as potential therapies... and design more specific compounds that t

ed funds to the American Alzheimer's Association, has heralded new findings into the late developing disease. The findings come from researchers at Mount Sinai Hospital in New York City, the Icelandic Heart Association, Sage Bionetworks and Merck Research Laboratories, who have determined that a cluster of genes co

ntly connected to Alzheimer's. The discovery is critical, Dr. Bin Zhang explained, a co-author of the study and Associate Professor of Genetics and Genomic Sciences at Mount Sinai. "We can now evaluate drugs that impact the TREM2- TYROBP pathway as potential therapies... and design more specific compounds that ta

ed funds to the American Alzheimer's Association, has heralded new findings into the late developing disease. The findings come from researchers at Mount Sinai Hospital in New York City, the Icelandic Heart Association, Sage Bionetworks and Merck Research Laboratories, who have determined that a cluster of genes co

onset of late Alzheimers. The discovery is critical, explains Dr. Bin Zhang, a co-lead author of the study and Associate Professor of Genetics and Genomic Sciences at Mount Sinai. Because we can now "evaluate drugs that impact the TREM2-TYROBP pathway as potential therapies... and design more specific compounds